Glenmark Pharmaceuticals Inc. USA has been granted approval from the Food and Drug Administration for linezolid tablets 600 mg, an antibiotic. Glenmark said its linezolid product is a therapeutic equivalent of Zyvox tablets 600 mg from Pfizer Inc.
A bipartisan coalition of congressmen is urging the participation of retail pharmacists in a new initiative to improve the use of medication therapy management (MTM) in Medicare. The National Association of Chain Drug Stores said Wednesday that 44 members of the U.S.
Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for olopatadine hydrochloride ophthalmic solution 0.1%. Aurobindo said its olopatadine HCl ophthalmic solution product is a generic version of Patanol ophthalmic solution/drops from Alcon, a Novartis company.
The Food and Drug Administration has established the Office of Dietary Supplement Programs (ODSP), raising the program from its previous status as a division under the Office of Nutrition Labeling and Dietary Supplements.
Coty Inc. has named Andraea Dawson-Shepherd as senior vice president of corporate affairs, a newly created position. The beauty care company said late Friday that in the role Dawson-Shepherd will lead Coty’s communication and corporate affairs agenda as it continues its expansion and transformation.
Both patients and pharmacists give high marks to medication synchronization programs, according to a recent survey by the National Community Pharmacists Association.
Walgreens Boots Alliance (WBA) Inc. has completed $12.8 billion in term loan facilities as part of the financing for its $17.2 billion deal to acquire Rite Aid Corp. WBA said Monday that the transactions include the placement of $5 billion of term loan facilities — split between two tranches of $2.
Longtime retail consultant/analyst Walter Loeb likes what he sees from CVS Health. In a Forbes article on Friday, Loeb described CVS as a compelling health and wellness destination, especially in the wake of its acquisition of Target Corp.
Tony Rogers reportedly has been appointed as chief marketing officer at Walmart. Published reports said Friday that Rogers, a 10-year company veteran who has been CMO of Walmart China for the past two years, succeeds Stephen Quinn, who is retiring.
Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. have received approval for Basaglar long-acting insulin (insulin glargine injection, 100 units/ml) in the United States.
Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil 9, its 9-valent human papillomavirus (HPV) vaccine.
Putting patients increasingly in control of their well-being and health care outcomes has truly come of age.
AstraZeneca plans to acquire the core respiratory business of Takeda Pharmaceutical Co. Ltd. for $575 million. Under the agreement, approximately 200 Takeda staff will transfer to AstraZeneca after the closing of the transaction, expected in the first quarter of 2016.
Rite Aid Corp. posted fiscal 2016 third-quarter adjusted earnings in line with Wall Street estimates and announced a special shareholders meeting to vote on its $17.2 billion deal to be acquired by Walgreens Boots Alliance Inc. Rite Aid said Thursday that for the third quarter ended Nov.
John Boehner, the former Speaker of the U.S. House of Representatives, will deliver the keynote address at the 2016 NACDS Annual Meeting. The National Association of Chain Drug Stores said that Boehner (R.
Peter Greenleaf, chief executive officer of Sucampo Pharmaceuticals Inc., has been appointed as chairman of the board. Sucampo said late Tuesday that Greenleaf, the company’s CEO and a board member since March 2014, is slated to take the reins as chairman on Jan. 1.
